Biological sex bias in clinical trials is a common issue in various medical fields, including gastroenterology and hepatology. Without sex parity and increased attention to sex-specific analyses, the translation of trial results into real-world clinical practice remains suboptimal with unpredictable consequences for patient care.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Insights and implications of sexual dimorphism in osteoporosis
Bone Research Open Access 18 February 2024
-
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine Open Access 25 September 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mauvais-Jarvis, F. et al. Sex and gender: modifiers of health, disease, and medicine. Lancet 396, 565–582 (2020).
Burra, P. et al. Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int. 41, 1713–1733 (2021).
Geller, S. E. et al. The more things change, the more they stay the same: a study to evaluate compliance with inclusion and assessment of women and minorities in randomized controlled trials. Acad. Med. 93, 630–635 (2018).
Zucker, I. & Prendergast, B. J. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol. Sex Differ. 11, 32 (2020).
Steinberg, J. R. et al. Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020. JAMA Netw. Open 4, e2113749 (2021).
Goodman, W. A., Erkkila, I. P. & Pizarro, T. T. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 740–754 (2020).
Klinge, I. Gender perspectives in European research. Pharmacol. Res. 58, 183–189 (2008).
Hertler, C., Seiler, A., Gramatzki, D., Schettle, M. & Blum, D. Sex-specific and gender-specific aspects in patient-reported outcomes. ESMO Open 5, e000837 (2020).
Russo, F. P., Burra, P. & Zanetto, A. COVID-19 and liver disease: where are we now? Nat. Rev. Gastroenterol. Hepatol. 19, 277–278 (2022).
Green, M. S. et al. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. Vaccines 10, 233 (2022).
Author information
Authors and Affiliations
Contributions
The authors contributed equally to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Burra, P., Zanetto, A. & Germani, G. Sex bias in clinical trials in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 19, 413–414 (2022). https://doi.org/10.1038/s41575-022-00638-2
Published:
Issue date:
DOI: https://doi.org/10.1038/s41575-022-00638-2
This article is cited by
-
Insights and implications of sexual dimorphism in osteoporosis
Bone Research (2024)
-
Hepatic immune regulation and sex disparities
Nature Reviews Gastroenterology & Hepatology (2024)
-
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
Nature Medicine (2023)
